Natural immunity against Haemophilus influenzae type a and B-cell subpopulations in adult patients with severe chronic kidney disease
Vaccine May 26, 2019
Gaultier GN, et al. - Among chronic kidney disease (CKD) (n=60) residents of a geographic region with a noticeable presence of Haemophilus influenzae type a (Hia) invasive disease, researchers assessed natural immunity against Hia and B-cell subpopulations so that the response to Hia immunization among immunocompromised Indigenous adults could be predicted. This study also included 35 healthy controls of the same age. Indigenous vs non-Indigenous patients had higher IgM antibody levels. A higher proportion of B cells (CD19+), class switched memory B cells (CD19+CD27+IgM-) and a lower proportion of CD19+CD27-IgM- B cells was seen in CKD patients vs healthy controls. Significantly higher proportions of IgM memory B cells and CD19+CD27-IgM- B cells were detected among non-Indigenous patients with CKD vs Indigenous patients with no significant variation in absolute numbers. Because re-activation of immunological memory against Hia could be potentially induced by a Hia-conjugate vaccine, this vaccine may be immunogenic in adult patients with CKD.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries